Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Europe
|
US/Canada
|
Japan
|
Asia (excluding Japan)
|
Latin America
|
Rest of World
|
International - Japan
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
Dr Reddy's ties up with Fujifilm for Japanese generics foray
28 July 2011
Mitsubishi buys into Fujifilm's contract biologics manufactu...
Pfizer and Ranbaxy forge consumer goods links to boost OTC s...
Japan to improve blood products independence through merger of plasma producers
23 June 2011
Takeda's azilsartan approved in the US
28 February 2011
SymBio raises $24 mn to advance bendamustine and other pipeline projects
28 February 2011
Daiichi Sankyo ups profit outlook, but weak spots mark nine-month figures
31 January 2011
>> More News...
LATEST ANALYSIS
2010 Scrip 100 - The tigers' roar
09 December 2009
Market Insight - Ontario's unknown opportunities
03 June 2009
Market Insight - The rise of the patient registry
08 May 2009
>> More Analysis...
LATEST FEATURES
Roche's Asian partnering head looks to tap regional innovation
14 October 2009
Stakeholders grapple with biosimilar issues at Japan meeting
18 February 2009
Japan's biosimilar guidelines edge forward
18 February 2009
>> More Features...
LATEST COMMENT
Commentary: Japan trims the fat
18 November 2009
Commentary: Asia's largest pharma event remarkably upbeat
08 July 2009
>> More Comment...
REFINE BY
COMPANY/ORGANISATION
PFIZER
NOVARTIS
GLAXOSMITHKLINE
TAKEDA
CONDITION
CANCER
DIABETES
ARTHRITIS
RHEUMATOID ARTHRITIS
GEOGRAPHY
JAPAN
CHINA
CANADA
GERMANY
DRUG
AMLODIPINE
BEVACIZUMAB
INFLIXIMAB
ETANERCEPT
